Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 2.1
5-Year Impact Factor – 2.2
Scopus CiteScore – 3.4 (CiteScore Tracker 3.4)
Index Copernicus  – 161.11; MEiN – 140 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2018, vol. 27, nr 5, May, p. 673–680

doi: 10.17219/acem/68634

Publication type: original article

Language: English

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

F2-isoprostanes and F4-neuroprostanes as markers of intracranial aneurysm development

Anna Syta-Krzyżanowska1,A,B,C,D,F, Iwona Jarocka-Karpowicz2,C, Jan Kochanowicz1,A,E,F, Grzegorz Turek3,B, Robert Rutkowski3,B, Krzysztof Gorbacz3,B, Zenon Mariak3,A,E, Elżbieta Skrzydlewska2,C,D,E,F

1 Department of Invasive Neurology, Medical University of Bialystok, Poland

2 Department of Analytical Chemistry, Medical University of Bialystok, Poland

3 Department of Neurosurgery, Medical University of Bialystok, Poland


Background. Intracranial aneurysms are common, occurring in about 1–2% of the population. Saccular aneurysm is a pouch-like pathological dilatation of an intracranial artery that develops when the cerebral artery wall becomes too weak to resist hemodynamic pressure and distends.
Objectives. The aim of this study was to determine whether the development of intracranial aneurysms and subarachnoid hemorrhage (SAH) affects neuronal phospholipid metabolism, and what influence different invasive treatments have on brain free radical phospholipid metabolism.
Material and Methods. The level of polyunsaturated fatty acid (PUFA) cyclization products – F2-isoprostanes and F4-neuroprostanes – was examined using liquid chromatography – mass spectrometry (LC-MS) in the plasma of patients with brain aneurysm and resulting subarachnoid hemorrhage.
Results. It was revealed that an aneurysm leads to the enhancement of lipid peroxidation with a significant increase in plasma F2-isoprostanes and F4-neuroprostanes (more than 3-fold and 11-fold, respectively) in comparison to healthy subjects. The rupture of an aneurysm results in hemorrhage and an additional increase in examined prostaglandin derivatives. The embolization and clipping of aneurysms contribute to a gradual restoration of metabolic homeostasis in brain cells, which is visible in the decrease in PUFA cyclization products.
Conclusion. The results indicate that aneurysm development is associated with enhanced inflammation and oxidative stress, factors which favor lipid peroxidation, particularly in neurons, whose membranes are rich in docosahexaenoic acid, a precursor of F4-neuroprostanes.

Key words

isoprostanes, neuroprostanes, aneurysm, subarachnoid hemorrhage

References (38)

  1. Tulamo R, Frozen J, Hernesniemi J, Niemela M. Inflammatory changes in the aneurysm wall: A review. J Neurointerv Surg. 2010;2(2):120–130.
  2. Chalouhi N, Hoh BL, Hasan D. Review of cerebral aneurysm formation, growth, and rupture. Stroke. 2013;44(12):3613–3622.
  3. Aoki T, Nishimura M, Kataoka H, et al. Reactive oxygen species modulate growth of cerebral aneurysms: A study using the free radical scavenger edaravone and p47phox (−/−) mice. Lab Invest. 2009;89(7):730–741.
  4. Nag S, Kapadia A, Stewart DJ. Review: Molecular pathogenesis of blood-brain barrier breakdown in acute brain injury. Neuropathol Appl Neurobiol. 2011;37(1):3–23.
  5. Joseph JA, Shukitt-Hale B, Casadeus G, Fisher D. Oxidative stress and inflammation in brain aging: Nutritional considerations. Neurochem Res. 2005;30(6/7):927–935.
  6. Li WJ. Research progress in the mechanism of brain self-repair [in Chinese]. Zhongguo Dang Dai Er Ke Za Zhi. 2011;13(7):606–611.
  7. Sadrzadeh SMH, Saffari Y. Iron and brain disorders. Am J Clin Pathol. 2004;121:64–70.
  8. Shila S, Kokilavani V, Subathra M, Panneerselvam C. Brain regional responses in antioxidant system to alpha-lipoic acid in arsenic intoxicated rat. Toxicology. 2005;210(1):25–36.
  9. Kerman M, Cirak B, Ozguner MF, et al. Does melatonin protect or treat brain damage from traumatic oxidative stress? Exp Brain Res. 2005;163:406–410.
  10. Mazza M, Pomponi M, Janiri L, Bria P, Mazza S. Omega-3 fatty acids and antioxidants in neurological and psychiatric diseases: An overview. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31(1):12–26.
  11. Catala A. Five decades with polyunsaturated fatty acids: Chemical synthesis, enzymatic formation, lipid peroxidation and its biological effects. J Lipids. 2013;2013:710290.
  12. Nkiki E. Biomarkers of lipid peroxidation in clinical material. Biochem Biophys Acta. 2014;1840(2):809–817.
  13. Fam SS, Murphey LJ, Terry ES, et al. Formation of highly reactive A-ring and J-ring isoprostane-like compounds (A4/J4-neuroprostanes) in vivo from docosahexaenoic acid. J Biol Chem. 2002;277(39):36076–36084.
  14. Miller E, Morel A, Saso L, Saluk J. Isoprostanes and neuroprostanes as biomarkers of oxidative stress in neurodegenerative diseases. Oxid Med Cell Longev. 2014;2014:572491.
  15. Milne GL, Yin H, Morrow JD. Human biochemistry of the isoprostane pathway. J Biol Chem. 2008;283(23):15533–15537.
  16. Teasdale G, Jennett B. Assessment of coma and impaired consciousness: A practical scale. Lancet. 1974;2:81–84.
  17. Hunt WE, Hess RM. Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg. 1968;28(1):14–20.
  18. Teasdale GM, Drake CG, Hunt W, et al. A universal subarachnoid hemorrhage scale: Report of a committee of the Word Federation of Neurosurgical Societies. J Neurol Neurosurg Psych. 1988;51(11):1457.
  19. Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurg. 1980;6:1–9.
  20. Coolen SA, van Buuren B, Duchateau G, Upritchard J, Verhagen H. Kinetics of biomarkers: Biological and technical validity of isoprostanes in plasma. Amino Acids. 2005;29(4):429–436.
  21. Łuczaj W, Moniuszko A, Rusak M, Pancewicz S, Zajkowska J, Skrzydlewska E. Lipid peroxidation products as potential bioindicators of Lyme arthritis. Eur J Clin Microbiol Infect Dis. 2011;30(3):415–422.
  22. Juvela S, Poussa K, Porras M. Factors affecting formation and growth of intracranial aneurysms: A long-term follow-up study. Stroke. 2001;32(2):485–491.
  23. Laaksamo E, Tulamo R, Liiman A, et al. Oxidative stress is associated with cell death, wall degradation, and increased risk of rupture of the intracranial aneurysm wall. Neurosurgery. 2013;72(1):109–117.
  24. Nurden AT. Platelets, inflammation and tissue regeneration. J Thromb Haemost. 2011;105(Suppl 1):S13–S33.
  25. Frosen J, Piippo A, Paetau A, et al. Remodeling of saccular cerebral artery aneurysm wall is associated with rupture: Histological analysis of 24 unruptured and 42 ruptured cases. Stroke. 2004;35(10):2287–2293.
  26. Bourre JM. Diet, brain lipids, and brain functions: Polyunsaturated fatty acids, mainly omega-3 fatty acids. In: Lajtha A, Vizi SE, eds. Handbook of Neurochemistry and Molecular Neurobiology. New York, NY: Springer US; 2009409–441.
  27. Lajtha A, ed. Handbook of Neurochemistry and Molecular Neurobiology: Neural Lipids. New York, NY: Springer US; 2010.
  28. Gueraud F, Atalay M, Bresgen N, et al. Chemistry and biochemistry of lipid peroxidation products. Free Radical Res. 2010;44(10):1098–1124.
  29. Halliwell B. Reactive oxygen species and the central nervous system. J Neurochem. 1992;59(5):1609–1623.
  30. Montuschi P, Barnes PJ, Roberts LJ. Isoprostanes: Markers and mediators of oxidative stress. FASEB J. 2004;18(15):1791–1800.
  31. Nowak JZ. Oxidative stress, polyunsaturated fatty acids-derived oxidation products and bisretinoids as potential inducers of CNS diseases: Focus on age-related macular degeneration. Pharmacol Rep. 2013;65(2):288–304.
  32. Halliwell B, Gutteridge J. Free Radicals in Biology and Medicine. 3rd ed. Oxford, UK: Oxford University Press; 1999.
  33. Starke RM, Chalouhi N, Ali MS, et al. The role of oxidative stress in cerebral aneurysm formation and rupture. Curr Neurovasc Res. 2013;10(3):247–255.
  34. Juvela S, Poussa K, Porras M. Natural history of unruptured intracranial aneurysms: Probability of and risk factors for aneurysm rupture. J Neurosurg. 2000;93(3):379–387.
  35. Dimitrov JD, Vassilev TL, Andre S, et al. Functional variability of antibodies upon oxidative processes. Autoimmun Rev. 2008;7:574–578.
  36. Nielsen MJ, Moestrup SK. Receptor targeting of hemoglobin mediated by the haptoglobins: Roles beyond heme scavenging. Blood. 2009;114(4):764–771.
  37. Naraoka M, Matsuda N, Shimamura N, Asano K, Ohkuma H. The role of arterioles and the microcirculation in the development of vasospasm after aneurysmal SAH. Biomed Res Int. 2014;2014:253746.
  38. Yu-Ping H, Chih-Lung L, An-Li S, et al. Correlation of F4-neuroprostanes levels in cerebrospinal fluid with outcome of aneurysmal subarachnoid hemorrhage in humans. Free Radic Biol Med. 2009;47(6):814–824.